J. B. Chemicals & Pharmaceuticals Limited





Market price today

  • 53.9217

    P/E Ratio

  • 8.5622

    PEG Ratio

  • 277.48B

    MRK Cap

  • 0.01%

    DIV Yield

J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM-NS) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Nikhil Ashokkumar Chopra
Full-time employees:5095
Address:Cnergy IT Park

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.

General Outlook

In simple terms, J. B. Chemicals & Pharmaceuticals Limited has 155.195 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.890% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.855%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.152%. This tells us they're good at keeping money after all costs.

Return on Investments

J. B. Chemicals & Pharmaceuticals Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.198%.

Stock Prices

J. B. Chemicals & Pharmaceuticals Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1714, while its low point bottomed out at $1651.15. This variance in figures offers investors a lucid insight into the roller-coaster ride that is J. B. Chemicals & Pharmaceuticals Limited's stock market.

Profitability Ratios

JBCHEPHARM.NS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 86.25% underscores its earnings before tax deductions. The effective tax rate stands at 4.77%, revealing its tax efficiency. The net income per EBT, 17.61%, and the EBT per EBIT, 100.85%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 85.52%, we grasp its operational profitability.

Pretax Profit Margin86.25%
Effective Tax Rate4.77%
Net Income per EBT17.61%
EBT per EBIT100.85%
EBIT per Revenue85.52%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 14.16, and free cash flow per share, 14.16, depict cash generation on a per-share basis. The cash per share value, 25.37, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.06, offers insight into cash flow relative to sales.

Operating Cash Flow per Share14.16
Free Cash Flow per Share14.16
Cash per Share25.37
Operating Cash Flow Sales Ratio0.06
Free Cash Flow to Operating Cash Flow Ratio1.00

Debt and Leverage Ratios

An interest coverage of 59.22 indicates its ability to manage interest expenses.

Interest Coverage59.22

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 20.86%, indicates top-line expansion, while the gross profit growth, 21.15%, reveals profitability trends. EBIT growth, -5.70%, and operating income growth, -5.70%, offer insights into operational profitability progression. The net income growth, 6.39%, showcases bottom-line expansion, and the EPS growth, -13.98%, measures the growth in earnings per share.

Revenue Growth20.86%
Gross Profit Growth21.15%
EBIT Growth-5.70%
Operating Income Growth-5.70%
Net Income Growth6.39%
EPS Growth-13.98%
EPS Diluted Growth-14.04%
Weighted Average Shares Diluted Growth0.09%
Dividends per Share Growth74.17%
Operating Cash Flow Growth-45.95%
Free Cash Flow Growth-300.99%
10-Year Revenue Growth per Share238.13%
5-Year Revenue Growth per Share90.16%
3-Year Revenue Growth per Share60.12%
10-Year Operating CF Growth per Share119.56%
5-Year Operating CF Growth per Share50.23%
3-Year Operating CF Growth per Share-6.29%
10-Year Net Income Growth per Share465.67%
5-Year Net Income Growth per Share222.01%
3-Year Net Income Growth per Share125.38%
10-Year Shareholders Equity Growth per Share129.27%
5-Year Shareholders Equity Growth per Share60.85%
3-Year Shareholders Equity Growth per Share53.34%
10-Year Dividend per Share Growth per Share1300.15%
5-Year Dividend per Share Growth per Share1241.00%
3-Year Dividend per Share Growth per Share552.41%
Receivables Growth49.01%
Inventory Growth17.99%
Asset Growth16.50%
Book Value per Share Growth17.93%
Debt Growth21.27%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 10.20, and the price to book ratio, 10.20, reflect the market's valuation relative to the company's book value. The price to sales ratio, 8.20, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 126.42, and price to operating cash flows, 126.30, gauge market valuation against cash flow metrics.

Price Book Value Ratio10.20
Price to Book Ratio10.20
Price to Sales Ratio8.20
Price Cash Flow Ratio126.30
Price Earnings to Growth Ratio8.56
Enterprise Value Multiple9.03
Price Fair Value10.20
Price to Operating Cash Flow Ratio126.30
Price to Free Cash Flows Ratio126.42
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) on the NSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 53.922 in 2024.

What is the ticker symbol of J. B. Chemicals & Pharmaceuticals Limited stock?

The ticker symbol of J. B. Chemicals & Pharmaceuticals Limited stock is JBCHEPHARM.NS.

What is company IPO date?

IPO date of J. B. Chemicals & Pharmaceuticals Limited is 2002-07-01.

What is company current share price?

Current share price is 1787.950 INR.

What is stock market cap today?

The market cap of stock today is 277480900250.000.

What is PEG ratio in 2024?

The current 8.562 is 8.562 in 2024.

What is the number of employees in 2024?

In 2024 the company has 5095.